Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-2-7
pubmed:abstractText
The CLSI clinical breakpoint (CBP) for echinocandin susceptibility (S; MICs of ? 2 ?g/ml) may classify isolates with acquired resistance (R) mutations as susceptible. Epidemiological cutoff values (ECVs) have been established to distinguish wild-type (WT) Candida strains from those that may exhibit R mutations. The CLSI-developed ECVs for anidulafungin, caspofungin, and micafungin were applied to 15,269 isolates of Candida spp. collected from over 100 centers worldwide between 2001 and 2009 to determine the frequency of non-WT strains of each species. The collection included 8,378 isolates of Candida albicans, 2,352 isolates of C. glabrata, 2,195 isolates of C. parapsilosis, 1,841 isolates of C. tropicalis, and 503 isolates of C. krusei. The mean percentages of non-WT isolates per year for anidulafungin, caspofungin, and micafungin, respectively, were as follows: for C. albicans, 0.3, 0.1, and 2.1; for C. glabrata, 0.8, 1.3, and 1.6; for C. parapsilosis, 0.0, 1.5, and 0.5; for C. tropicalis, 0.9, 0.7, and 0.9; and for C. krusei, 0.5, 6.4, and 3.5. We noted increases in the percentage of non-WT isolates, from 0.5% (2001) to 3.1% (2009) for caspofungin and C. parapsilosis, from 0.4% (2004) to 1.8% (2009) for anidulafungin and C. glabrata, from 2.4% (2004) to 5.7% (2009) for micafungin and C. krusei, and from 0.0% (2004) to 3.1% (2009) for micafungin and C. parapsilosis. No trends were noted for any species and drug when we used the CBP. Echinocandin CBPs are insensitive for detecting emerging R. Although uncommon, decreased S among Candida isolates was observed for each of the echinocandins and varied by species. Using ECVs is important in determining R trends among echinocandins and Candida.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-12837738, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-16464893, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-16511756, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-16517851, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-16643517, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-16716141, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-17325225, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-17468115, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-17569573, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-17630331, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-18032613, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-18378714, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-18579718, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-18591282, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-18676885, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-18794385, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-18794386, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-18955538, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-19104024, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-19188378, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-19191635, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-19546367, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-19741524, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-19884370, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-19923478, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-20016020, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-20036518, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-20038613, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-20335424, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-20368396, http://linkedlifedata.com/resource/pubmed/commentcorrection/21147948-20421445
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1098-660X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
624-9
pubmed:dateRevised
2011-8-3
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin.
pubmed:affiliation
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242-1009, USA. michael-pfaller@uiowa.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't